skip to main content

H.R. 1919 (113th): Safeguarding America’s Pharmaceuticals Act of 2013

Call or Write Congress

To amend the Federal Food, Drug, and Cosmetic Act with respect to the pharmaceutical distribution supply chain, and for other purposes.

The bill’s titles are written by its sponsor.

Sponsor and status

Robert Latta

Sponsor. Representative for Ohio's 5th congressional district. Republican.

Read Text »
Last Updated: Jun 4, 2013
Length: 100 pages
May 9, 2013
113th Congress (2013–2015)
Died in a previous Congress

This bill was introduced in a previous session of Congress and was passed by the House on June 3, 2013 but was never passed by the Senate. Provisions of this bill were incorporated into other bills.

Although this bill was not enacted, its provisions could have become law by being included in another bill. It is common for legislative text to be introduced concurrently in multiple bills (called companion bills), re-introduced in subsequent sessions of Congress in new bills, or added to larger bills (sometimes called omnibus bills).

Provisions of this bill also appear in:

H.R. 3204: Drug Quality and Security Act
Enacted — Signed by the President on Nov 27, 2013. (compare text)

20 Cosponsors (15 Republicans, 5 Democrats)


Position statements

What legislators are saying

Latta Comments on President Signing Legislation to Combat Counterfeit Pharmaceuticals
    — Rep. Robert Latta [R-OH5] (Sponsor) on Nov 27, 2013

Upton Hails House Passage of Critical Health Bills to Support Animal Drug Programs, Secure Prescription Drug Supply Chain
    — Rep. Fred Upton [R-MI6, 1993-2022] (Co-sponsor) on Jun 3, 2013

Collins, King Pledge to Defend Maine Patient Safety, Papermaking Interests
    — Sen. Angus King [I-ME] on Jun 4, 2013

More statements at ProPublica Represent...


May 9, 2013

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

May 14, 2013
Considered by House Committee on Energy and Commerce

A committee held a hearing or business meeting about the bill.

Jun 3, 2013
Passed House (Senate next)

The bill was passed in a vote in the House. It goes to the Senate next. The vote was by voice vote so no record of individual votes was made.

Jun 3, 2013
Text Published

Updated bill text was published as of Reported by House Committee.

H.R. 1919 (113th) was a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Bills numbers restart every two years. That means there are other bills with the number H.R. 1919. This is the one from the 113th Congress.

This bill was introduced in the 113th Congress, which met from Jan 3, 2013 to Jan 2, 2015. Legislation not passed by the end of a Congress is cleared from the books.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 1919 — 113th Congress: Safeguarding America’s Pharmaceuticals Act of 2013.” 2013. March 25, 2023 <>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from, the official portal of the United States Congress. is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.